Lv41
404 积分 2021-07-07 加入
Current understanding and new insights in the treatment of IgA nephropathy
26分钟前
已完结
Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
40分钟前
已完结
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial
2天前
已完结
Effect of long-term belimumab treatment on b cells in systemic lupus erythematosus: Extension of a phase II, double-blind, placebo-controlled, dose-ranging study†
2天前
已完结
Targeting B Cells and Plasma Cells in Glomerular Disease
2天前
已完结
2024版KDIGO《慢性肾脏病评估与管理临床实践指南》更新要点及解读
3天前
已完结
慢性肾脏病的治疗核心是延缓疾病进展和长期达标——访中华医学会肾脏病学分会副主任委员赵明辉教授
3天前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
4天前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
4天前
已完结
Disease modifying therapies in diabetes and endocrinology
7天前
已完结
皖公网安备34019202002308
